289 related articles for article (PubMed ID: 23208048)
21. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
22. A MicroRNA Derived from Adenovirus Virus-Associated RNAII Promotes Virus Infection via Posttranscriptional Gene Silencing.
Wakabayashi K; Machitani M; Tachibana M; Sakurai F; Mizuguchi H
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355689
[TBL] [Abstract][Full Text] [Related]
23. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
24. Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse.
McClane SJ; Hamilton TE; DeMatteo RP; Burke C; Raper SE
Pancreas; 1997 Oct; 15(3):236-45. PubMed ID: 9336786
[TBL] [Abstract][Full Text] [Related]
25. Effects of adeno-associated virus on adenovirus replication and gene expression during coinfection.
Timpe JM; Verrill KC; Trempe JP
J Virol; 2006 Aug; 80(16):7807-15. PubMed ID: 16873238
[TBL] [Abstract][Full Text] [Related]
26. Second-generation adenovirus vectors.
Wang Q; Finer MH
Nat Med; 1996 Jun; 2(6):714-6. PubMed ID: 8640568
[No Abstract] [Full Text] [Related]
27. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.
Brough DE; Hsu C; Kulesa VA; Lee GM; Cantolupo LJ; Lizonova A; Kovesdi I
J Virol; 1997 Dec; 71(12):9206-13. PubMed ID: 9371579
[TBL] [Abstract][Full Text] [Related]
28. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.
Ramalingam R; Worgall S; Rafii S; Crystal RG
Mol Ther; 2000 Oct; 2(4):381-6. PubMed ID: 11020354
[TBL] [Abstract][Full Text] [Related]
30. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
[TBL] [Abstract][Full Text] [Related]
31. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
32. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
33. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-regulated transgene expression systems for gene therapy and virotherapy.
Sakurai F; Katayama K; Mizuguchi H
Front Biosci (Landmark Ed); 2011 Jun; 16(6):2389-401. PubMed ID: 21622184
[TBL] [Abstract][Full Text] [Related]
35. Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration.
Kumar-Singh R; Farber DB
Hum Mol Genet; 1998 Nov; 7(12):1893-900. PubMed ID: 9811932
[TBL] [Abstract][Full Text] [Related]
36. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
37. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
Eslami MH; Gangadharan SP; Sui X; Rhynhart KK; Snyder RO; Conte MS
J Vasc Surg; 2000 Jun; 31(6):1149-59. PubMed ID: 10842152
[TBL] [Abstract][Full Text] [Related]
38. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
Zhou H; Beaudet AL
Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
[TBL] [Abstract][Full Text] [Related]
39. Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells.
Koizumi N; Kondoh M; Mizuguchi H; Nakanishi T; Masuyama A; Ida F; Fujii M; Hayakawa T; Nakashima E; Tanaka K; Watanabe Y
Placenta; 2005 Nov; 26(10):729-34. PubMed ID: 16226122
[TBL] [Abstract][Full Text] [Related]
40. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
Zhou H; O'Neal W; Morral N; Beaudet AL
J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
